Insurance · Updated November 4, 2026
Wegovy Insurance Coverage in 2026: Plans, Costs, Workarounds
Novo Nordisk lists Wegovy at $1,349.02 per package. NovoCare self-pay runs $149 to $399/mo depending on form and dose. Standard Medicare does not cover weight-loss drugs, but the temporary Medicare GLP-1 Bridge does for eligible people.
1. Wegovy coverage by payer type
| Plan type | What to expect | Cost if not covered |
|---|---|---|
| Employer or marketplace plan with obesity benefit | May be covered, usually with prior authorization | Copay set by your plan, $25 floor with savings card |
| Plan without obesity benefit | Usually excluded for weight loss | $149 to $399 (NovoCare) |
| Medicare (standard Part D) | Drugs used only for weight loss are excluded. Plans may cover Wegovy for its cardiovascular risk-reduction indication. | Not eligible for the savings card |
| Medicare GLP-1 Bridge | Covered for eligible Part D beneficiaries, July 1, 2026 to December 31, 2027 (CMS) | $50 copay, no low-income subsidy |
| Medicaid | Varies by state | Not eligible for the savings card |
2. Wegovy savings card and NovoCare
Two Novo Nordisk programs lower out-of-pocket cost:
- Wegovy savings card: for commercially insured patients whose plan covers Wegovy. Pay as little as $25 a month, with savings capped at $100 a month. Government beneficiaries are excluded (NovoCare terms).
- NovoCare self-pay: no insurance needed. Pill: $149/mo for 1.5 mg, $199/mo for 4 mg, $299/mo for 9 mg and 25 mg. Pen: $349/mo, or $199/mo for the first two monthly fills of 0.25 mg and 0.5 mg for new patients through December 31, 2026. Wegovy HD 7.2 mg pen: $399/mo (NovoCare, Wegovy.com, checked November 4, 2026).
Novo Nordisk announced it will cut the US list price of Wegovy 2.4 mg and the 25 mg tablet to $675 a month from January 1, 2027. That mainly helps people whose costs track list price, such as high-deductible plans. It does not change self-pay prices.
3. How to check coverage on your specific plan
- Call the member-services number on your insurance card
- Ask: "Does my plan cover Wegovy (semaglutide) for chronic weight management?"
- If yes, ask: "What tier is it on the formulary, and what is the copay?"
- Ask: "Is prior authorization required, and what are the requirements?"
- Ask: "Are step-therapy drugs required first?"
If you are denied, your prescriber can ask the plan for an exception or file an appeal.
4. Prior authorization requirements (typical)
Criteria vary by plan. They often mirror the Wegovy label:
- BMI of 30 or more, or 27 or more with a weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol
- For the cardiovascular indication, established cardiovascular disease plus obesity or overweight
- Some plans ask for documented prior weight-loss attempts or step therapy
- The label says not to use Wegovy with a personal or family history of medullary thyroid carcinoma or with MEN 2
5. Telehealth providers offering Wegovy
We track 14 programs that offer brand-name Wegovy or branded semaglutide. 11 accept insurance. 3 are cash-pay only. Prices are program fees from our provider data and may not include the drug.
| Provider | $/mo | Insurance |
|---|---|---|
| WeightWatchers Clinic | $74 | Yes |
| Hello Alpha | $79 | Yes |
| JumpstartMD | $99 | Yes |
| Sesame | $99 | Yes |
| Everlywell | $99 | Cash-pay only |
| Mochi Health | $139 | Yes |
| Ro | $149 | Yes |
| LifeMD | $149 | Yes |
| Calibrate | $199 | Yes |
| Options Medical Weight Loss | $199 | Yes |
| Measured | $199 | Yes |
| Form Health | $299 | Yes |
| Lemonaid Health | $348 | Cash-pay only |
| Pallas Health | $599 | Cash-pay only |
6. If Wegovy is not covered: cheaper paths
- NovoCare self-pay: from $149/mo for the pill and $349/mo for the pen ($199/mo for the first two months for new patients on starter doses). Works without insurance.
- Compounded semaglutide: advertised at $77 to $348/mo in our provider data. It is not FDA-approved or a generic, and FDA does not review compounded products for safety, effectiveness or quality before marketing. Talk to your prescriber first. See our compounded semaglutide list.
- Ask about Zepbound: a different drug (tirzepatide) with its own coverage rules and self-pay prices.
- Medicare beneficiaries: check eligibility for the Medicare GLP-1 Bridge ($50 copay through December 31, 2027).
- Appeal the denial: your prescriber can document why you meet the plan's criteria.
FAQ
Is Wegovy covered by insurance in 2026?
It depends on whether your plan covers obesity medications. Many plans that do require prior authorization. Standard Medicare Part D excludes drugs used only for weight loss, but eligible beneficiaries can get Wegovy for a $50 copay through the Medicare GLP-1 Bridge from July 1, 2026 to December 31, 2027. Medicaid coverage varies by state.
How much does Wegovy cost without insurance?
Novo Nordisk lists Wegovy at $1,349.02 per package. Through NovoCare self-pay (checked November 4, 2026), the pill costs $149/mo for 1.5 mg, $199/mo for 4 mg and $299/mo for 9 mg and 25 mg. The pen costs $349/mo, with $199/mo for the first two months on 0.25 mg and 0.5 mg for new patients through December 31, 2026. Wegovy HD 7.2 mg costs $399/mo.
What is the Wegovy savings card?
A Novo Nordisk copay offer for people with commercial insurance that covers Wegovy. Eligible patients pay as little as $25 a month, with savings capped at $100 a month. Government beneficiaries are excluded. If your plan does not cover Wegovy, NovoCare self-pay pricing applies instead.
What is the prior authorization process for Wegovy?
Plans set their own criteria. Many ask your prescriber to document that you meet the FDA label, such as a BMI of 30 or more, or 27 or more with a weight-related condition, and some ask about prior weight-loss attempts. Ask your plan for its written criteria.
Is compounded semaglutide cheaper than Wegovy?
Advertised prices are often lower: $77 to $348/mo in our provider data, against $149 to $399/mo for Wegovy through NovoCare. Compounded semaglutide is not FDA-approved, is not a generic Wegovy, and is rarely covered by insurance.
What we checked
This AI-assisted public-source desk check reviewed NovoCare's Wegovy pricing page and savings offer terms, Wegovy.com savings page, the CMS Medicare GLP-1 Bridge page, Novo Nordisk's February 24, 2026 list price announcement and the Wegovy label on November 4, 2026. We removed employer-coverage and appeal-success percentages we could not trace to a primary source. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.